Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in ALVO — Alvotech

CIK 1000275 TORONTO, A6
Back to ALVO Full portfolio

Position in ALVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$638
+$90 QoQ
Shares Held
173
+8.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 72 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. ALVO ranks #59 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
 9,213,269 $133,500,266
2 ZTS
Zoetis Inc.
 1,828,326 $131,383,499
3 NBIX
Neurocrine Biosciences Inc
 583,476 $98,339,041
4 BHC
Bausch Health Companies Inc.
 10,832,582 $53,404,627
5 VTRS
Viatris Inc
 3,135,460 $49,791,098
6 UTHR
UNITED THERAPEUTICS Corp
 62,600 $33,918,552
7 TEVA
Teva Pharmaceutical Industries Ltd
 953,413 $32,301,629
8 HLN
Haleon plc
 3,385,489 $31,586,609

All Filings in ALVO

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $638 173
2026-03-31 $548 160
2025-12-31 $866 169
2025-09-30 $28,532 3,484
2025-06-30 $5,225 573
2025-03-31 $5,947 615
2024-12-31 $1,587 120
2024-06-30 $109 9
2024-03-31 $16,337 1,337
2023-12-31 $2,192 191
2023-09-30 $1,732 190
2023-06-30 $2,948 381